Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
QuintilesIMS
Julphar
Argus Health
Queensland Health
Fuji
Express Scripts
Cerilliant

Generated: January 22, 2019

DrugPatentWatch Database Preview

Testosterone enanthate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for testosterone enanthate and what is the scope of testosterone enanthate freedom to operate?

Testosterone enanthate is the generic ingredient in three branded drugs marketed by Endo Pharms, Hikma Farmaceutica, Mylan Institutional, Nexus Pharms, Watson Labs, Watson Pharms Inc, and Antares Pharma Inc, and is included in eight NDAs. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Testosterone enanthate has forty-three patent family members in twelve countries.

There are sixty-nine drug master file entries for testosterone enanthate. Three suppliers are listed for this compound.

Pharmacology for testosterone enanthate
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists

US Patents and Regulatory Information for testosterone enanthate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-003 Sep 28, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Harvard Business School
Chubb
AstraZeneca
QuintilesIMS
Accenture
Moodys
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.